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Clinical implications: We present the first description of a male with X-chromosome 
mosaicism who has clinical features of the X-linked CGD carrier state and passed a CYBB 
mutation to a daughter and subsequently affected grandson: clinicians should be aware of this 
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To the Editor, 1 
 2 
Chronic Granulomatous Disease (CGD) is a genetic primary immunodeficiency caused by 3 
mutations in the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase enzyme 4 
complex. This leads to impaired production of reactive oxygen species and impaired killing 5 
of ingested bacteria and fungi. About two thirds of cases are in males with X-linked CGD 6 
caused by mutations in the CYBB gene, coding for gp91phox, found at Xp21.1-p11.4 [1]; in 7 
approximately 10-12% of families these CYBB mutations are believed to arise de novo.  8 
Female carriers of X-linked CGD exhibit a range of phenotypes, although in one series 37% 9 
were completely asymptomatic and 52% had no features of CGD disease [2]. Common 10 
manifestations in those who are symptomatic include recurrent oral ulceration, photosensitive 11 
rashes and discoid lupus erythematosus (DLE) [2-4], the latter seen in between 9% [2] and 12 
40% [3] depending on population. They can also be affected by gastrointestinal conditions 13 
similar to classic inflammatory bowel disease (approximately 4% [2, 3]) and have an 14 
increased predisposition to other lupus-like autoimmune manifestations. Female carriers can 15 
also present with recurrent or suppurative infections (15% had severe infections in a recent 16 
report [2]) and indeed with extremely skewed lyonisation they can essentially develop the full 17 
CGD syndrome [1]. Thus the carriage state can also confer a significant burden of disease. 18 
We present a patient who was identified after his grandson was diagnosed with X-linked 19 
CGD. The grandson, who is the index case, was noted to have abnormal neutrophil functional 20 
tests and a c.1253C>T (p.Ser418Phe) CYBB mutation, and has subsequently undergone 21 
haematopoietic stem cell transplantation. During family screening his mother was found to be 22 
a carrier of this variant, but not his maternal grandmother. It was noted that instead his 23 
maternal grandfather had some features consistent with a carrier state. This person (the 24 
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maternal grandfather of the index case) is 51 years old with a history of asthma, epilepsy, 25 
hypertension and a significant infection history with two previous episodes of pneumonia or 26 
“pleurisy” and two episodes of cellulitis. He reported sun sensitivity, arthralgia and frequent 27 
‘blistering’ of the lips. He had previously been referred to dermatology with a rash on his 28 
upper chest that was diagnosed on biopsy as Jessner’s lymphocytic infiltrate of the skin 29 
(JLIS) (Figure 1A & 1B) treated successfully with hydroxychloroquine. JLIS demonstrates 30 
very similar characteristics clinically and on histological examination to discoid lupus 31 
erythematosus [5]. He reported recurrent lower respiratory tract infection requiring antibiotics 32 
as a child and a requirement for antibiotics twice a year even in adulthood. A CT chest 33 
showed mild left lower lobe bronchiectasis (Figure 1C).  34 
This maternal grandfather of the index case was found to have an abnormal Nitro-blue 35 
tetrazolium (NBT) test and dihydrorhodamine (DHR) oxidation, both of which demonstrated 36 
two populations of neutrophils upon stimulation, one capable of respiratory burst and one 37 
with an impaired burst (Figure 2A & 2B). This was confirmed on repeated testing. Gp91phox 38 
expression in these cells showed one positive and one negative peak (Figure 2C). Genetic 39 
analysis from blood and a salivary sample via Ion Torrent™ next generation sequencing 40 
confirmed that he in fact has three X-chromosome variants, two of which carry a novel CYBB 41 
mutation at position c.1253 (c.1253C>T  [p.Ser418Phe] in 44% of reads, c.1253C>G 42 
[p.Ser418Cys] in 7-8% of reads and the remainder wild-type; Supplementary Figure 1). He 43 
had undergone vasectomy and thus could not provide a semen sample for further analysis. 44 
The brother and the three other daughters of the maternal grandfather of the index case 45 






It has previously been reported that male patients with X-linked CGD can have small 50 
populations of normal cells [6], suggesting mutation in early embryogenesis, or early 51 
reversion in some cell lines after the mutation arose in the oocytes. There has also been a case 52 
report of an X-linked CGD patient’s brother with Klinefelter’s syndrome having carrier status 53 
[7], due to inheritance of both the mutated allele of CYBB and the normal allele. Case reports 54 
of triple mosaic female carriers who had populations of neutrophils with two different 55 
deletion mutations in CYBB and the normal variant have been described [8], as has a late-56 
onset somatic mutation in CYBB with subsequent mosaicism in haematopoietic cells in a 57 
female [9]. However, this is the first report to our knowledge of a fertile male acting as a true 58 
‘carrier’ for X-linked CGD with a compatible clinical syndrome (the ‘JLIS’ is likely to 59 
represent discoid lupus as seen in the CGD carrier state) and inheritance of the disease-60 
causing variant in offspring. Both wild-type and mutant forms were present in blood and 61 
saliva: this raises the possibility of either early reversion of a germline mutation during 62 
embryogenesis or a mutation arising during an early multicellular stage with both populations 63 
of cells increasing proportionally. Given that there is no evidence that his brother has the 64 
mutation or clinically that there are other carriers in the family before him we conclude it is 65 
likely that this is a de novo mutation.  66 
Male carriage of X-linked conditions in this manner would not be picked up via routine 67 
genetic screening of affected families and can lead to unintentional inheritance of the 68 
mutation without appropriate genetic counselling. Indeed in this case the maternal 69 
grandfather passed the gene on to one of his four daughters who subsequently had an affected 70 
child. There is a potential for grandfathers who are mosaics for X-linked conditions to pass 71 
on the genetic mutation to future children and, in diseases such as CGD, carriers themselves 72 
can develop symptoms and significant morbidity.  We therefore recommend that clinicians 73 
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are aware of this possibility and consider at least functional testing of maternal grandfathers 74 
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Figure 1. A. Photograph of the rash diagnosed as Jessner’s lymphocytic infiltrate (diameter 
approximately 2cm). B. Histology from a skin lesion demonstrating superficial and deep 
dermal perivascular inflammation, normal epidermis on low power (left) and detail of the 
predominantly lymphocytic infiltrate on higher power (right). C. Axial section from CT 
thorax showing dilated bronchi larger than accompanying blood vessels, consistent with mild 
bronchiectasis (arrows). 
 
Figure 2. A. NBT test (see Supplementary methods). The maternal grandfather of the index 
case (‘patient’, right) demonstrates two populations of cells, one able and one unable to 
reduce NBT and form blue formazan. B. Dihydrorhodamine test (see Supplementary 
methods). Rhodamine-1,2,3-FITC results are shown for a control (left) and the maternal 
grandfather of the index case (‘patient’, right) without stimulation (red histogram) and after 
stimulation with PMA (blue histogram), again indicating two cell populations in the maternal 
grandfather. C. gp91phox expression (see Supplementary methods) in neutrophils; isotype 
control (red histogram) and gp91phox stained (blue histogram) results are shown for a control 
(left) and the maternal grandfather of the index case (‘patient’, right) who has a population of 
gp91phox-negative cells. D. Family pedigree based on Ion Torrent™ next generation 
sequencing, indicating transmission of presumed deleterious CYBB mutation from the 
maternal grandfather to one daughter and then to a grand-son (index case) who presented 





















NBT test. This was performed in accordance with published reports [1]. Briefly, 100 μl of 
EDTA whole blood was incubated with 100 μl of 0.2% NBT (Sigma) and 100 μl of 10 μg/ml 
phorbol 12-myristate 13-acetate (PMA) (Sigma) for 25 minutes at 37oC, then 25 minutes at 
room temperature before mixing with 500 μl of 2% acetic acid and trace crystal violet; 10-μl 
aliquots were added to counting slides and examined at x40 magnification. 
DHR test. This was performed in accordance with published reports [2]. The PhagoBurst™ 
kit (Glycotope Biotechnology) was used on heparinised whole blood according to 
manufacturers’ instructions and samples processed on a FACSCalibur flow cytometer. For 
analysis a DNA stain was used to identify live cells and then neutrophils were gated by 
forward and side scatter (Figure 2). 
Gp91phox expression. This was determined in neutrophils (gated by forward and side scatter; 
Figure 2) via flow cytometry using 7D5 mAb against gp91phox (IgG1, LifeSpan BioSciences) 
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Supplementary Figure Legend 
Supplementary Figure 1. Results of Ion Torrent™ next generation sequencing of the CYBB 
gene in the patient’s blood and saliva. 
 
 
 
